On June 8, 2018 it was my honor to present to the Kentucky Osteopathic Medical Association (KOMA) an update regarding requirements to prescribe controlled substances, particularly opioids, for chronic pain patients in Kentucky. It is nearly impossible to cover every important aspect of this subject in one hour, however I gave it an earnest effort. And as I promised the gracious KOMA attendees, what follows is the principal content of my presentation. To my osteopath colleagues, I thank you for all that you do, and I deeply appreciate the invitation to present at your annual meeting.

Dropbox link for related documents of interest:

https://www.dropbox.com/sh/onebv2dyj0f3qpa/AACo4LxBLYmGLcSvy7MKxdEBa?dl=0

Related links of interest:

Kentucky Board of Medical Licensure (KBML website)

https://kbml.ky.gov/Pages/index.aspx

Considerations for Patient Education (KBML)

https://kbml.ky.gov/hb1/Pages/Considerations-For-Patient-Education.aspx

CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016

https://www.cdc.gov/drugoverdose/prescribing/guideline.html

THE CHRONIC PAIN PATIENT’S GUIDE TO KENTUCKY’S REGULATIONS<

https://jamespmurphymd.com/2015/02/13/pathway-to-partnership/

PLAN TO THINK… HOW TO PRESCRIBE CONTROLLED SUBSTANCES IN KENTUCKY FOR THE FIRST THREE MONTHS

https://jamespmurphymd.com/2015/06/

ARE WE IN AGREEMENT? …One Pain Specialist’s Take on the Controlled Substances Prescriber-Patient Agreement